Neurology in New Jersey

Professional Surgical Instruments Co., Inc. is a comprehensive manufacturer and distributor of surgical instruments serving the global medical, dental, and veterinary markets. Based in East Brunswick, New Jersey, the company specializes in precision-engineered stainless steel surgical instruments across multiple specialties. Their extensive product portfolio includes forceps, needle holders, scissors, retractors, clamps, elevators, rongeurs, and specialized instruments for cardiothoracic, orthopedic, neurosurgical, laparoscopic, microsurgical, ophthalmic, ENT, OB/GYN, dermatology, plastic surgery, and pediatric procedures. The company also manufactures dental surgical instruments, endodontic tools, orthodontic instruments, periodontal instruments, and restorative dental tools. Products are available in both individual instruments and pre-assembled surgical sets. Professional Surgical Instruments maintains a B2B focus, offering medical device manufacturing expertise and a detailed surgical instrument catalog to hospitals, surgical centers, dental practices, and veterinary clinics worldwide.

electroCore is a bioelectronic medicine company specializing in non-invasive vagus nerve stimulation (nVNS) technology. The company develops and commercializes proprietary nVNS devices designed to treat various neurological and immunological disorders. Their flagship product, gammaCore, is a wearable nVNS device that stimulates the vagus nerve to deliver therapeutic benefits for conditions including migraine, cluster headache, PTSD, and mild traumatic brain injury. The company has published clinical evidence in peer-reviewed journals demonstrating the efficacy of nVNS therapy across multiple indications. electroCore positions itself as a pioneer in bioelectronic medicine, leveraging vagus nerve stimulation as a drug-free, non-invasive therapeutic approach. The company is publicly traded on NASDAQ and actively pursues investigator-led clinical trials to expand the therapeutic applications of their nVNS platform. Their products are designed for patient self-administration and home use, making them accessible to broader patient populations.

JOGO Health is a digital therapeutics company specializing in FDA-registered Class II EMG biofeedback systems for pain and neuromuscular disorder management. The platform integrates wearable sensors with advanced AI to leverage neuroplasticity, delivering non-invasive, medication-free virtual rehabilitation. Founded on research by Dr. Joseph Brudny (NYU) and Dr. Gordon Silverman (Rockefeller University), JOGO combines Electromyography biofeedback, Pain Neuroscience Education, Pain Reprocessing Therapy, and physical therapy. Clinical trials at Brigham and Women's Hospital (Harvard) and Mayo Clinic demonstrated superior outcomes versus opioids for chronic pain and superiority over standard care for neuromuscular disorders. The platform enables hybrid or fully virtual tele-rehabilitation, allowing home-based therapy. Medicare and major commercial payers cover JOGO for migraine, tension-type headache, cancer pain, urinary incontinence, pelvic pain, fecal incontinence, chronic constipation, stroke recovery, and neurorehabilitation. Indicated conditions include Parkinson's, Essential Tremor, cerebral palsy, Bell's palsy, spinal cord injury, and multiple sclerosis.

Soterix Medical is the global leader in non-invasive neuromodulation and integrated brain monitoring technology. The company designs, manufactures, and markets advanced research and clinical-grade systems for transcranial electrical stimulation (tDCS, tES, HD-tES), transcranial magnetic stimulation (TMS, MEGA-TMS), transcranial focused ultrasound stimulation (tFUS), and related modalities. Research platforms include 1x1 tDCS/tES systems, high-definition HD-tES platforms, temporal interference stimulation (TI), taVNS (transcutaneous auricular vagus nerve stimulation), galvanic vestibular stimulation, and fully integrated multimodal solutions combining stimulation with EEG, fMRI, PET, and fNIRS. Clinical systems target depression (tDCS-LTE), pain conditions (PainX tDCS and TENS), and major depressive disorder (SPRY TMS). The company also offers neurotargeting software (HD-Explore, HD-Targets, tDCS-Explore), mobile EEG systems, and animal pre-clinical stimulation systems. Soterix holds FDA 510(k) clearances for multiple products including Depression tDCS-LTE, SPRY TMS, IontoDC, MEGA-IOM intraoperative neuromonitoring, and Neural Navigator TMS neuronavigation. CE Mark approvals exist for 1x1 tDCS depression and PainX pain treatment. The company serves academic research centers, clinical institutions, and specialized neurology and psychiatry practices worldwide. Manufacturing and quality standards reflect commitment to precision, usability, and regulatory compliance across research and clinical applications.

NeuroMetrix, Inc. is a neurotechnology company specializing in non-invasive medical devices for diagnosing and treating pain and neurological disorders. The company develops point-of-care neuropathy diagnostic tests and FDA-approved wearable neurostimulation devices. Its Quell® platform is a wearable neuromodulator designed for chronic pain management and fibromyalgia symptom reduction. DPNCheck provides rapid nerve conduction testing for peripheral neuropathy evaluation. NeuroMetrix targets healthcare professionals including endocrinologists and podiatrists, as well as direct consumers. Founded in 1996 and based in Woburn, Massachusetts, the company is a wholly-owned subsidiary of electroCore, Inc. and is publicly traded on Nasdaq (NURO). The company emphasizes innovation in digital medicine and neurostimulation through clinical feedback and research.